Emerging Applications of Nanotechnology in Healthcare and Medicine.

Shiza Malik, Khalid Muhammad, Yasir Waheed
Author Information
  1. Shiza Malik: Bridging Health Foundation, Rawalpindi 46000, Pakistan.
  2. Khalid Muhammad: Department of Biology, College of Science, UAE University, Al Ain 15551, United Arab Emirates. ORCID
  3. Yasir Waheed: Office of Research, Innovation and Commercialization, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad 44000, Pakistan. ORCID

Abstract

Knowing the beneficial aspects of nanomedicine, scientists are trying to harness the applications of nanotechnology in diagnosis, treatment, and prevention of diseases. There are also potential uses in designing medical tools and processes for the new generation of medical scientists. The main objective for conducting this research review is to gather the widespread aspects of nanomedicine under one heading and to highlight standard research practices in the medical field. Comprehensive research has been conducted to incorporate the latest data related to nanotechnology in medicine and therapeutics derived from acknowledged scientific platforms. Nanotechnology is used to conduct sensitive medical procedures. Nanotechnology is showing successful and beneficial uses in the fields of diagnostics, disease treatment, regenerative medicine, gene therapy, dentistry, oncology, aesthetics industry, drug delivery, and therapeutics. A thorough association of and cooperation between physicians, clinicians, researchers, and technologies will bring forward a future where there is a more calculated, outlined, and technically programed field of nanomedicine. Advances are being made to overcome challenges associated with the application of nanotechnology in the medical field due to the pathophysiological basis of diseases. This review highlights the multipronged aspects of nanomedicine and how nanotechnology is proving beneficial for the health industry. There is a need to minimize the health, environmental, and ethical concerns linked to nanotechnology.

Keywords

References

  1. ACS Appl Bio Mater. 2022 Mar 21;5(3):971-1012 [PMID: 35226465]
  2. Nanomaterials (Basel). 2022 Jul 16;12(14): [PMID: 35889665]
  3. Nat Biotechnol. 2021 Nov;39(11):1348-1365 [PMID: 34750572]
  4. J Nanobiotechnology. 2022 Jan 4;20(1):4 [PMID: 34983555]
  5. Nanomedicine (Lond). 2020 Sep;15(21):2085-2102 [PMID: 32723142]
  6. Nanomaterials (Basel). 2023 Feb 10;13(4): [PMID: 36839060]
  7. Nanomedicine (Lond). 2022 Feb;17(3):133-136 [PMID: 35012366]
  8. Med Res Rev. 2018 Sep;38(6):2110-2136 [PMID: 29846948]
  9. Minim Invasive Ther Allied Technol. 2010 Jun;19(3):144-56 [PMID: 20497067]
  10. Semin Cancer Biol. 2021 Feb;69:166-177 [PMID: 31715247]
  11. Ther Deliv. 2020 Jul;11(7):411-414 [PMID: 32594863]
  12. Adv Mater. 2020 Apr;32(13):e1901989 [PMID: 31286573]
  13. Mol Pharm. 2021 Feb 1;18(2):550-575 [PMID: 32519875]
  14. Med Sci Monit. 2020 Mar 22;26:e921040 [PMID: 32200389]
  15. ACS Nano. 2018 Jan 23;12(1):24-43 [PMID: 29257865]
  16. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1598 [PMID: 31793237]
  17. J Nanosci Nanotechnol. 2017 Jan;17(1):18-28 [PMID: 29616786]
  18. Trends Biotechnol. 2008 Jan;26(1):39-47 [PMID: 18036685]
  19. Mater Sci Eng C Mater Biol Appl. 2021 Aug;127:112199 [PMID: 34225852]
  20. Molecules. 2023 Jan 09;28(2): [PMID: 36677717]
  21. Sci Rep. 2017 Oct 23;7(1):13738 [PMID: 29062065]
  22. Dent Mater. 2020 Nov;36(11):1365-1378 [PMID: 32981749]
  23. Pharmaceutics. 2023 Jul 03;15(7): [PMID: 37514058]
  24. Smart Mater Med. 2020;1:10-19 [PMID: 34553138]
  25. Curr Opin Biotechnol. 2022 Apr;74:241-246 [PMID: 34995920]
  26. J Funct Biomater. 2023 Jan 14;14(1): [PMID: 36662094]
  27. Futur J Pharm Sci. 2022;8(1):12 [PMID: 35071609]
  28. ACS Nano. 2019 Nov 26;13(11):13015-13026 [PMID: 31689086]
  29. Bioorg Chem. 2019 Apr;85:325-336 [PMID: 30658232]
  30. Macromol Rapid Commun. 2022 Jun;43(12):e2100754 [PMID: 35286740]
  31. Drug Discov Today. 2010 Oct;15(19-20):842-50 [PMID: 20727417]
  32. ACS Omega. 2023 Feb 08;8(7):6325-6336 [PMID: 36844542]
  33. Vaccines (Basel). 2022 Oct 16;10(10): [PMID: 36298592]
  34. Nanoscale Adv. 2021 Feb 22;3(8):2157-2179 [PMID: 36133769]
  35. Biomater Sci. 2022 Dec 6;10(24):6862-6892 [PMID: 36222758]
  36. Pharmaceutics. 2020 Dec 09;12(12): [PMID: 33317067]
  37. Nano Today. 2021 Aug;39: [PMID: 34899962]
  38. Mater Today Bio. 2022 Feb 01;13:100208 [PMID: 35198957]
  39. ACS Nano. 2019 Nov 26;13(11):12732-12742 [PMID: 31647640]
  40. Biomaterials. 2020 Dec;261:120332 [PMID: 32877764]
  41. Nanomaterials (Basel). 2023 Mar 31;13(7): [PMID: 37049340]
  42. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jul;13(4):e1700 [PMID: 33511770]
  43. Adv Healthc Mater. 2021 Aug;10(15):e2002205 [PMID: 34085411]
  44. ACS Nano. 2013 Sep 24;7(9):7442-7 [PMID: 24490875]
  45. J Drug Target. 2022 Apr;30(4):349-358 [PMID: 34706620]
  46. Biomaterials. 2014 Jul;35(20):5359-5368 [PMID: 24720877]
  47. Nanoscale. 2021 Jun 17;13(23):10266-10280 [PMID: 34085085]
  48. J Anaesthesiol Clin Pharmacol. 2022 Jan-Mar;38(1):11-17 [PMID: 35706631]
  49. Nanomedicine. 2015 Jul;11(5):1253-63 [PMID: 25791811]
  50. Regen Biomater. 2021 Jun 14;8(3):rbab023 [PMID: 34211733]
  51. Pharmaceutics. 2023 Feb 17;15(2): [PMID: 36840008]
  52. Appl Biochem Biotechnol. 2022 Sep;194(9):4187-4219 [PMID: 35551613]
  53. Biol Trace Elem Res. 2020 Sep;197(1):70-88 [PMID: 31782063]
  54. Int J Nanomedicine. 2023 Jul 19;18:3913-3935 [PMID: 37489141]
  55. Environ Sci Pollut Res Int. 2020 Jun;27(16):19073-19086 [PMID: 30547342]
  56. Sci Adv. 2020 Jun 26;6(26):eabb8133 [PMID: 32637625]
  57. Front Bioeng Biotechnol. 2020 May 05;8:381 [PMID: 32432092]
  58. Cancer Metastasis Rev. 2022 Jun;41(2):383-404 [PMID: 35366154]
  59. J Control Release. 2015 Nov 10;217:345-51 [PMID: 26264835]
  60. Micromachines (Basel). 2022 Apr 19;13(5): [PMID: 35630115]
  61. Nanomedicine (Lond). 2022 Feb;17(4):255-270 [PMID: 35109687]
  62. RSC Adv. 2020 Apr 20;10(26):15430-15460 [PMID: 35495474]
  63. Nat Nanotechnol. 2023 Jul;18(7):692-695 [PMID: 37106055]
  64. Nat Rev Drug Discov. 2010 Aug;9(8):615-27 [PMID: 20616808]
  65. Int J Nanomedicine. 2017 Apr 12;12:2957-2978 [PMID: 28442906]
  66. Pharmaceutics. 2022 Jul 29;14(8): [PMID: 36015202]
  67. J Biomed Mater Res A. 2019 May;107(5):978-990 [PMID: 30665262]
  68. Front Med (Lausanne). 2021 Jun 04;8:648005 [PMID: 34150793]
  69. Mater Sci Eng C Mater Biol Appl. 2019 May;98:1252-1276 [PMID: 30813007]
  70. Bioinorg Chem Appl. 2022 Mar 17;2022:1946724 [PMID: 35340422]
  71. Nanomaterials (Basel). 2020 Aug 09;10(8): [PMID: 32784939]
  72. Semin Cancer Biol. 2023 Feb;89:61-75 [PMID: 36682438]
  73. Cureus. 2022 Sep 11;14(9):e29059 [PMID: 36259014]
  74. Int J Mol Sci. 2021 Mar 04;22(5): [PMID: 33806682]
  75. Bioeng Transl Med. 2019 Sep 05;4(3):e10143 [PMID: 31572799]
  76. Nano Lett. 2020 Jun 10;20(6):4264-4269 [PMID: 32357299]
  77. J Control Release. 2020 May 10;321:442-462 [PMID: 32067996]
  78. Biosensors (Basel). 2023 Apr 16;13(4): [PMID: 37185556]
  79. Nanomaterials (Basel). 2020 Oct 05;10(10): [PMID: 33027891]
  80. RSC Adv. 2021 Jun 15;11(34):21189-21206 [PMID: 35479373]
  81. J Control Release. 2021 Oct 10;338:119-136 [PMID: 34418520]
  82. Nat Commun. 2023 Jan 24;14(1):392 [PMID: 36693842]
  83. Theranostics. 2023 Mar 21;13(6):1974-2014 [PMID: 37064867]
  84. Chem Rev. 2019 May 22;119(10):6459-6506 [PMID: 29465222]
  85. J Pharm Investig. 2023;53(1):19-33 [PMID: 36568502]
  86. Curr Opin Biotechnol. 2020 Jun;63:135-141 [PMID: 32035339]
  87. Anticancer Res. 2017 Nov;37(11):5975-5981 [PMID: 29061776]
  88. Int J Nanomedicine. 2013;8:2305-17 [PMID: 23836972]
  89. Vaccines (Basel). 2021 Apr 08;9(4): [PMID: 33918072]
  90. Pharmaceutics. 2022 May 19;14(5): [PMID: 35631677]
  91. Vet Med Sci. 2023 Jan;9(1):494-506 [PMID: 36580403]
  92. J Control Release. 2020 Feb;318:256-263 [PMID: 31846618]
  93. Biomed Rep. 2021 May;14(5):42 [PMID: 33728048]
  94. Int J Nanomedicine. 2021 Feb 17;16:1313-1330 [PMID: 33628022]
  95. Adv Drug Deliv Rev. 2022 Feb;181:114083 [PMID: 34929251]
  96. J Intern Med. 2010 Jan;267(1):89-105 [PMID: 20059646]
  97. Int J Nanomedicine. 2022 Aug 26;17:3735-3749 [PMID: 36051353]
  98. Nanoscale. 2021 Jul 28;13(28):12198-12211 [PMID: 34231613]
  99. Nat Commun. 2021 Jul 16;12(1):4374 [PMID: 34272375]
  100. Genes Dev. 2013 Nov 15;27(22):2397-408 [PMID: 24240230]
  101. Adv Sci (Weinh). 2021 May 16;8(14):2100540 [PMID: 34306980]
  102. Hum Exp Toxicol. 2015 Dec;34(12):1318-21 [PMID: 26614822]
  103. J Appl Toxicol. 2022 Jan;42(1):41-51 [PMID: 34050552]
  104. ACS Omega. 2019 May 22;4(5):8804-8815 [PMID: 31459969]
  105. Emergent Mater. 2021;4(1):75-99 [PMID: 33615140]
  106. Int J Nanomedicine. 2022 Jan 28;17:443-462 [PMID: 35115777]

Word Cloud

Created with Highcharts 10.0.0nanotechnologymedicalnanomedicinebeneficialaspectstreatmentresearchfieldNanotechnologyscientistsapplicationsdiagnosisdiseasesusesreviewmedicinetherapeuticsdiseaseindustryhealthKnowingtryingharnesspreventionalsopotentialdesigningtoolsprocessesnewgenerationmainobjectiveconductinggatherwidespreadoneheadinghighlightstandardpracticesComprehensiveconductedincorporatelatestdatarelatedderivedacknowledgedscientificplatformsusedconductsensitiveproceduresshowingsuccessfulfieldsdiagnosticsregenerativegenetherapydentistryoncologyaestheticsdrugdeliverythoroughassociationcooperationphysicianscliniciansresearcherstechnologieswillbringforwardfuturecalculatedoutlinedtechnicallyprogramedAdvancesmadeovercomechallengesassociatedapplicationduepathophysiologicalbasishighlightsmultiprongedprovingneedminimizeenvironmentalethicalconcernslinkedEmergingApplicationsHealthcareMedicinedrug-deliveryhealthcarenanobiotechnology

Similar Articles

Cited By